bf/NASDAQ:ASND_icon.jpeg

COM:ASCENDISPHARMA

Ascendis Pharma

  • Stock

USD

Last Close

122.64

22/11 21:00

Market Cap

7.78B

Beta: -

Volume Today

378.33K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
20.41M
-
13.98M
31.48%
8.12M
41.94%
4.61M
43.26%
1.53M
66.78%
10.58M
591.57%
13.38M
26.41%
6.95M
48.01%
7.78M
11.87%
51.17M
557.93%
266.72M
421.20%
cost of revenue
3.52M
-
12.14M
244.51%
44.40M
265.78%
gross profit
20.41M
-
13.98M
31.48%
8.12M
41.94%
4.61M
43.26%
1.53M
66.78%
10.58M
591.57%
13.38M
26.41%
6.95M
48.01%
4.25M
38.80%
39.04M
817.44%
222.32M
469.52%
selling and marketing expenses
general and administrative expenses
2.42M
-
6.27M
159.69%
9.41M
50.06%
11.50M
22.19%
13.48M
17.19%
25.06M
85.86%
48.47M
93.45%
selling general and administrative expenses
2.42M
-
6.27M
159.69%
9.41M
50.06%
11.50M
22.19%
13.48M
17.19%
25.06M
85.86%
48.47M
93.45%
76.67M
58.17%
160.18M
108.92%
221.23M
38.11%
264.41M
19.52%
research and development expenses
12.71M
-
19.70M
54.94%
40.53M
105.75%
66.02M
62.90%
99.59M
50.84%
140.28M
40.86%
191.62M
36.60%
260.90M
36.16%
295.87M
13.40%
379.62M
28.31%
413.45M
8.91%
other expenses
cost and expenses
15.13M
-
25.97M
71.67%
49.94M
92.30%
77.53M
55.23%
113.07M
45.85%
165.34M
46.22%
240.09M
45.21%
337.57M
40.60%
459.57M
36.14%
612.99M
33.38%
722.26M
17.83%
operating expenses
15.13M
-
25.97M
71.67%
49.94M
92.30%
77.53M
55.23%
113.07M
45.85%
165.34M
46.22%
240.09M
45.21%
337.57M
40.60%
456.05M
35.10%
600.85M
31.75%
677.86M
12.82%
interest expense
8K
-
16K
100%
6K
62.50%
5K
16.67%
97K
1,840.00%
127K
30.93%
1.22M
861.42%
1.92M
57.08%
3.91M
103.91%
50.49M
1,190.90%
44.06M
12.72%
ebitda
5.68M
-
-11.48M
302.06%
-41.25M
259.20%
-72.12M
74.82%
-109.88M
52.36%
-150.18M
36.67%
-217.03M
44.51%
-328.88M
51.54%
-423.67M
28.82%
-527.33M
24.47%
-438.17M
16.91%
operating income
5.28M
-
-11.99M
327.11%
-41.83M
248.86%
-72.92M
74.35%
-111.54M
52.96%
-154.76M
38.74%
-226.72M
46.50%
-330.62M
45.83%
-451.79M
36.65%
-561.81M
24.35%
-455.54M
18.92%
depreciation and amortization
405K
-
504K
24.44%
558K
10.71%
677K
21.33%
734K
8.42%
880K
19.89%
9.69M
1,001.14%
1.74M
82.08%
28.12M
1,520.05%
34.48M
22.61%
18.91M
45.16%
total other income expenses net
-566K
-
1.67M
394.17%
8.24M
395.14%
4.07M
50.63%
-13.66M
435.60%
20.37M
249.15%
8.47M
58.43%
-88.55M
1,145.63%
67.85M
176.62%
-16.00M
123.59%
8.61M
153.77%
income before tax
4.71M
-
-10.34M
319.77%
-33.57M
224.70%
-68.73M
104.72%
-124.37M
80.96%
-130.49M
4.92%
-218.25M
67.25%
-419.17M
92.06%
-383.94M
8.40%
-577.82M
50.50%
-474.14M
17.94%
income tax expense
626K
-
-682K
208.95%
-652K
4.40%
-227K
65.18%
-477K
110.13%
-394K
17.40%
-234K
40.61%
-219K
6.41%
-367K
67.58%
5.38M
1,565.12%
7.30M
35.82%
net income
4.08M
-
-9.66M
336.77%
-32.92M
240.88%
-68.50M
108.08%
-123.90M
80.86%
-130.10M
5.00%
-218.02M
67.58%
-418.95M
92.17%
-383.58M
8.44%
-583.19M
52.04%
-481.45M
17.45%
weighted average shs out
10.80M
-
16.94M
56.78%
23.77M
40.33%
26.56M
11.77%
33.63M
26.58%
41.09M
22.18%
46.51M
13.20%
50.62M
8.84%
54.77M
8.21%
56.07M
2.37%
56.29M
0.38%
weighted average shs out dil
10.80M
-
16.94M
56.78%
23.77M
40.33%
26.56M
11.77%
33.63M
26.58%
41.09M
22.18%
46.51M
13.20%
50.62M
8.84%
54.77M
8.21%
56.07M
2.37%
56.29M
0.38%
eps
0.38
-
-0.57
250%
-1.39
143.86%
-2.58
85.61%
-3.68
42.64%
-3.17
13.86%
-4.69
47.95%
-8.28
76.55%
-7
15.46%
-10.40
48.57%
-8.55
17.79%
epsdiluted
0.38
-
-0.57
250%
-1.39
143.86%
-2.58
85.61%
-3.68
42.64%
-3.17
13.86%
-4.69
47.95%
-8.28
76.55%
-7
15.46%
-10.40
48.57%
-8.55
17.79%

All numbers in USD (except ratios and percentages)